Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Replimune Group, Inc.
13G/A
Amendment 1
REPL · 76029N106
|
8.7%
Checked 5% or less
|
8/14/2026
Event 6/30/2026
|
|||
| Ridgeback Capital Investments L.P. | 8.7% | ||||
| Ridgeback Capital Investments LLC | 8.7% | ||||
| Ridgeback Capital Management LLC | 8.7% | ||||
|
Replimune Group, Inc.
13G
REPL · 76029N106
|
7.6% |
5/21/2026
Event 5/14/2026
|
|||
| Ridgeback Capital Investments L.P. | 7.6% | ||||
| Ridgeback Capital Investments LLC | 7.6% | ||||
| Ridgeback Capital Management LLC | 7.6% | ||||
|
Lenz Therapeutics, Inc.
13G/A
Amendment 1
LENZ · 52635N103
|
0% |
2/17/2026
Event 12/31/2025
|
|||
| Ridgeback Capital Investments L.P. | 0% | ||||
| Ridgeback Capital Investments LLC | 0% | ||||
| Ridgeback Capital Management LLC | 0% | ||||
|
Semler Scientific, Inc.
13G/A
Amendment 1
SMLR · 81684M104
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Ridgeback Capital Investments L.P. | 0% | ||||
| Ridgeback Capital Investments LLC | 0% | ||||
| Ridgeback Capital Management LLC | 0% | ||||
|
iTeos Therapeutics, Inc.
13G/A
Amendment 1
ITOS · 46565G104
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Ridgeback Capital Investments L.P. | 0% | ||||
| Ridgeback Capital Investments LLC | 0% | ||||
| Ridgeback Capital Management LLC | 0% | ||||
|
iTeos Therapeutics, Inc.
13G
ITOS · 46565G104
|
5.1% |
7/25/2025
Event 7/21/2025
|
|||
| Ridgeback Capital Investments L.P. | 5.1% | ||||
| Ridgeback Capital Investments LLC | 5.1% | ||||
| Ridgeback Capital Management LLC | 5.1% | ||||
|
Semler Scientific, Inc.
13G
SMLR · 81684M104
|
6.9% |
7/16/2025
Event 7/11/2025
|
|||
| Ridgeback Capital Investments L.P. | 6.9% | ||||
| Ridgeback Capital Investments LLC | 6.9% | ||||
| Ridgeback Capital Management LLC | 6.9% | ||||
|
iTeos Therapeutics, Inc.
13G
ITOS · 46565G104
|
3.8% |
6/4/2025
Event 5/28/2025
|
|||
| Ridgeback Capital Investments L.P. | 3.8% | ||||
| Ridgeback Capital Investments LLC | 3.8% | ||||
| Ridgeback Capital Management LLC | 3.8% | ||||
|
Affimed N.V.
13G/A
Amendment 4
AFMDQ · N01045207
|
0% |
5/20/2025
Event 5/16/2025
|
|||
| Ridgeback Capital Investments L.P. | 0% | ||||
| Ridgeback Capital Investments LLC | 0% | ||||
| Ridgeback Capital Management LLC | 0% | ||||
|
Pyxis Oncology, Inc.
13G/A
Amendment 1
PYXS · 747324101
|
0.6% |
2/14/2025
Event 12/31/2024
|
|||
| Ridgeback Capital Investments L.P. | 0.6% | ||||
| Ridgeback Capital Investments LLC | 0.6% | ||||
| Ridgeback Capital Management LLC | 0.6% | ||||